Postpartum haemorrhage (PPH) rates in randomized trials of PPH prophylactic interventions and the effect of underlying participant PPH risk: a meta-analysis

[1] Say L(2014)Global causes of maternal death: a WHO systematic analysis Lancet Glob Health 2 323-333

[2] Chou D(2016)On behalf of the Royal College of Obstetricians and Gynaecologists Prevention and management of postpartum haemorrhage BJOG Int J Obstet Gynaecol 124 e106-ee49

[3] Gemmill A(2016)The epidemiology and outcomes of women with postpartum haemorrhage requiring massive transfusion with eight or more units of red cells: a national cross-sectional study BJOG Int J Obstet Gynaecol 123 2164-2170

[4] Tuncalp O(2015)Is accurate and reliable blood loss estimation the 'crucial step' in early detection of postpartum haemorrhage: an integrative review of the literature BMC Pregnancy Childbirth 15 230-187

[5] Moller AB(2017)Physiological adaptation of maternal plasma volume during pregnancy: a systematic review and meta-analysis Ultrasound Obstet Gynecol 49 177-877

[6] Daniels J(2001)A randomized controlled trial comparing oxytocin administration before and after placental delivery in the prevention of postpartum hemorrhage Am J Obstet Gynecol 185 873-299

[7] Mavrides EAS(2005)Maternal hemodynamics after oxytocin bolus compared with infusion in the third stage of labor: a randomized controlled trial Obstet Gynecol 105 294-e44

[8] Chandraharan E(2016)Oxytocin via Uniject (a prefilled single-use injection) versus oral misoprostol for prevention of postpartum haemorrhage at the community level: a cluster-randomised controlled trial Lancet Glob Health 4 e37-624

[9] Collins P(2010)Using Intraumbilical vein injection of oxytocin in routine practice with active Management of the Third Stage of labor: a randomized controlled trial Obstet Gynecol 116 619-102

[10] Green L(2011)Administration of 400 μg of misoprostol to augment routine active management of the third stage of labor Int J Gynaecol Obstet 112 98-151

[1] Say L(2014)Global causes of maternal death: a WHO systematic analysis Lancet Glob Health 2 323-333

[2] Chou D(2016)On behalf of the Royal College of Obstetricians and Gynaecologists Prevention and management of postpartum haemorrhage BJOG Int J Obstet Gynaecol 124 e106-ee49

[3] Gemmill A(2016)The epidemiology and outcomes of women with postpartum haemorrhage requiring massive transfusion with eight or more units of red cells: a national cross-sectional study BJOG Int J Obstet Gynaecol 123 2164-2170

[4] Tuncalp O(2015)Is accurate and reliable blood loss estimation the 'crucial step' in early detection of postpartum haemorrhage: an integrative review of the literature BMC Pregnancy Childbirth 15 230-187

[5] Moller AB(2017)Physiological adaptation of maternal plasma volume during pregnancy: a systematic review and meta-analysis Ultrasound Obstet Gynecol 49 177-877

[6] Daniels J(2001)A randomized controlled trial comparing oxytocin administration before and after placental delivery in the prevention of postpartum hemorrhage Am J Obstet Gynecol 185 873-299

[7] Mavrides EAS(2005)Maternal hemodynamics after oxytocin bolus compared with infusion in the third stage of labor: a randomized controlled trial Obstet Gynecol 105 294-e44

[8] Chandraharan E(2016)Oxytocin via Uniject (a prefilled single-use injection) versus oral misoprostol for prevention of postpartum haemorrhage at the community level: a cluster-randomised controlled trial Lancet Glob Health 4 e37-624

[9] Collins P(2010)Using Intraumbilical vein injection of oxytocin in routine practice with active Management of the Third Stage of labor: a randomized controlled trial Obstet Gynecol 116 619-102

[10] Green L(2011)Administration of 400 μg of misoprostol to augment routine active management of the third stage of labor Int J Gynaecol Obstet 112 98-151